Cysteamine Attenuates Iminodipropionitrile (IDPN) Induced Dyskinesia in Rats

References

• Addonizio G., Alexopoulos G. S. Drug-induced dystonia in young and elderly patients. American Journal of Psychiatry 1988; 145: 869–871
   PubMed Web of Science ®Google Scholar
• Adler L. A., Angrist B., Reiter S., Rotrosen J. Neuroleptic-induced akathisia: a review. Psychopharmacology 1989; 4: 222–226
   Google Scholar
• Akanmu D., Cecchini R., Aruoma O., Halliwell B. The antioxidant action of ergothioneine. Archives of Biochemistry and Biophysics 1991; 288: 10–16
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Tardive dyskinesia: A task force report of the American Psychiatric Association. Washington, DCUSA 1992
   Google Scholar
• Araujo D. M., Lapchak P. A., Collier B., Quirion R. Evidence that somatostatin enhances endogenous acetylcholine release in the rat hippocampus. Journal of Neurochemistry 1990; 55: 1546–1555
   PubMed Web of Science ®Google Scholar
• Aruoma O., Halliwell B., Hoey B., Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochemical Journal 1988; 256: 251–255
   PubMed Web of Science ®Google Scholar
• Bangalore R., Hawthorn M., Triggle D. J. Iminodipropionitrile induced dyskinesia in mice: Striatal calcium channel changes and sensitivity to calcium channel antagonist. Journal of Neurochemistry 1991; 57: 550–555
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Lohr J. B., Jeste D. V. Free radical and developmental pathobiology. Trends in Neurosciences 1986; 9: 107–108
   Web of Science ®Google Scholar
• Cadet J. L., Braun T., Freed W. J. The dopamine D-2 antagonist, Ro 22—1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile in mice. Experimental Neurology 1987; 96: 594–600
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Braun T., Freed W. J. Clonidine and prazosin block the iminodipropionitrile (IDPN) induced spasmodic dyskinetic syndrome in mice. Pharmacology, Biochemistry and Behaviour 1987a; 26: 791–795
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Taylor E., Freed W. J. The iminodipropionitrile induced dyskinetic syndrome in mice: Antagonism by the calcium channel antagonist, nifedipine. Pharmacology, Biochemistry and Behaviour 1988; 29: 381–385
   PubMed Web of Science ®Google Scholar
• Cadet J. L., Lohr J. B. Possible involvement of free radicals in neuroleptic induced movement disorders: evidence from treatment of tardive dyskinesia with vitamin E. Annals of New York Academy of Sciences 1989; 570: 176–185
   PubMed Web of Science ®Google Scholar
• Chou S. M., Hartman H. A. Axonal lesions and waltzing syndrome after IDPN administration in rats. Acta Neuropathologica 1964; 3: 428–450
   PubMedGoogle Scholar
• Chouinard G., Annable L., Ross-Chouinard A., Mercier P. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. Journal of Clinical Psychopharmacology 1988; 8: 215–265, Suppl 4
   Web of Science ®Google Scholar
• Dexter D. T., Ward R. J., Wells F. R., Daniel S. E., Lees A. J., Peters T. J., Jenner P., Marsden C. D. Alpha tocopherol levels in brain are not altered in parkinson's disease. Annals of Neurology 1992; 32: 591–593
   PubMed Web of Science ®Google Scholar
• Diamond B. I., Reyes M. G., Borison R. A new animal model for Tourette syndrome. Giles de la Tourette Syndrome, AJ Friedhoff, TN Chase. Raven Press, New York 1982; 221–225
   Google Scholar
• Diamond B. I., Sethi K., Borison R. C. Serotonin modulation of hyperkinesia and phasic neck dystonia induced by iminodipropionitrile (IDPN) in rats. Neurology 1986; 36: 341, (suppl 1)
   Web of Science ®Google Scholar
• DiLiberato E. J., DiStefano V., Smith J. C. Mechanism and kinetics of the inhibition of dopamine-β-hydroxylase by 2-mercaptoethylguanidine. Biochemical Pharmacology 1973; 22: 2961–2972
   PubMed Web of Science ®Google Scholar
• Egan M. F., Thomal M. H., Gregory W. Treatment of tardive dyskinesia with vitamin E. American Journal Of Psychiatry 1992; 147: 505–506
   Web of Science ®Google Scholar
• Fornai F., Alessandri M., Saginario A., Vaglini F., Corsini G. β,β-Iminodipropionitrile-induced persistent dyskinetic syndrome in mice is transiently modified by MPTP. Brain Research 1993; 605: 93–100
   PubMed Web of Science ®Google Scholar
• Fuchs J., Huflejt M., Rothfuss L., Wilson D., Cancamo G., Packer L. Impairment of enzymic and nonenzymic antioxidants in skin by UVB irradiation. Journal of Investive Dermatology 1989; 93: 769–773
   PubMed Web of Science ®Google Scholar
• Ganzini L., Casey D., Hoffman W., McCall A. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Archives of Internal Medicine 1993; 153: 1469–1475
   PubMed Web of Science ®Google Scholar
• Gillies N. E., Prise K. M., Michael B. D., Fahey R. The role of charge in intracellular radioprotection by thiols. British Journal of Radiology 1992; 24: 32–34, Suppl
   Google Scholar
• Haenen G. R., Vermeulen N. P., Timmerman H., Bast A. Effect of thiols on lipid peroxidation in rat liver microsomes. Chemistry, Biology and Interaction 1989; 71(2–3)201–212
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxidants and the central nervous system: some fundamental questions. Acta Neurologica Scandavia 1989; 126: 23–33
   Google Scholar
• Haroutunian V., Mantin R., Campbell G. A., Tsuboyama G. K., Davies K. L. Cysteamine-induced depletion of central somatostatin-like immunoreactivity: effects on behaviour, learning, memory and brain neurochemistry. Brain Research 1987; 403: 234–242
   PubMed Web of Science ®Google Scholar
• Hirata H., Ogawa N., Asanuma M., Ota 2., Mori A. Effect of chronic ceruletide treatment on dopaminergic neurotransmitters, receptors and thier mRNAs in the striatum of rats with dyskinesia induced by iminodipropionitrile. Brain Research 1993; 604(1–2)197–204
   PubMed Web of Science ®Google Scholar
• Ip C., Ganther H. E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 1992; 13(7)1167–1170
   PubMed Web of Science ®Google Scholar
• Irwin S. Comprehensive observational assessment: la. A systematic quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychophamcologia 1968; 13: 222–257
   PubMed Web of Science ®Google Scholar
• Jeitner T. M., Oliver J. R. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats. Journal of Endocrinology 1990; 127(1)119–127
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Phelps B. H., Wagner R. L., Wise C. D., Wyatt R. J. Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia (letter). Lancet 1979; 2(8147)850–851
   PubMed Web of Science ®Google Scholar
• Jeste D. V., Doongaji D. R., Linnola M. Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia. British Journal of Psychiatry 1984; 144: 177–180
   PubMed Web of Science ®Google Scholar
• Kane J. M., Smith J. M. Tardive dyskinesia. Archives of General Psychiatry 1982; 39: 473–481
   PubMed Web of Science ®Google Scholar
• Langlais P. J., Huang P. C., Gabay S. Effects of neuropharmacologic agents on a chemically induced hyperkinetic animal model. International Journal of Neurology 1977; 12: 97–117
   Google Scholar
• Llorens J., Crofton K., O'Callaghan J. Administration of 3.3′-iminodipropionitrile to the rat results in region-dependent damage to the central nervous system at levels above the brain stem. Journal of Pharmacology and Experimental Therapeutics 1993; 265(3)1392–1498
   PubMed Web of Science ®Google Scholar
• Lohr J. B., Cadet J. L., Lohr M. A., Jeste D. V., Wyatt R. J. Alpha tocopherol in tardive dyskinesia. Lancet 1987; 1: 913–914
   PubMed Web of Science ®Google Scholar
• Martin J. M., Michael K. M., Gary G. G., Charles B. A. Protective effects of glycine during hypothermic renal ischemia-reperfusion injury. American Journal of Physiology 1991; 261: F841–F848
   Google Scholar
• Matsouka N., Maeda N., Yamaguchi I., Satoh M. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Research 1994; 642: 11–19
   PubMed Web of Science ®Google Scholar
• McCulloch W., Scheffler B. J., Scein P. S. New protective agents for bone marrow in cancer therapy. Cancer Investigation 1991; 9: 279–287
   PubMed Web of Science ®Google Scholar
• Metz A., Goodwin G. M., Green A. R. The administration of baclofen increases 5-HT-2-mediated head-twitch behavior and 5-HT receptor number in frontal cortex. Neuropharmacology 1985; 24: 357–360
   PubMed Web of Science ®Google Scholar
• Millard W. J., Sagar S. M., Badger T. M., Cam D. B., Arnold M. A., Spindel E., Kasting N. W., Martin J. B. The effects of cysteamine on thyrotropin and immunoreactive β-endorphin secretion in the rat. Endocrinology 1983; 112: 518–525
   PubMed Web of Science ®Google Scholar
• Mithofer K., Sandy M. S., Smith M. T. Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes. Archives of Biochemistry and Biophysics 1992; 295: 132–136
   PubMed Web of Science ®Google Scholar
• Moser V. C., Boyes W. K. Prolong neurobehavioral and visual effects of short-time exposure to 3.3′-iminodipropionitrile (IDPN) in rats. Fundamental Applied Toxicology 1993; 21: 277–290
   PubMedGoogle Scholar
• Ogawa N., Mizukawa K., Haba K., Sato H. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. European Neurology 1990; 30: 31–40, (suppl 1)
   PubMed Web of Science ®Google Scholar
• Oishi T., Hasegawa E., Murai Y. Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3.6-tetrahydropyridine (MPTP) in the mouse. Journal of Neural Transmission 1993; 6: 45–52
   Web of Science ®Google Scholar
• Owen W. G. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Analytical Biochemistry 1980; 106: 207–212
   PubMed Web of Science ®Google Scholar
• Palkovits M., Brownstein M. J., Eiden L. E., Beinfeld M. C., Arimura A., Szabo S. Selective depletion of somatostatin in rat brain by cysteamine. Brain Research 1982; 240: 178–180
   PubMed Web of Science ®Google Scholar
• Pall H. S., Williams A. C., Blahed D. R., Lunec J. Evidence of enhanced lipid peroxidation in the cerehrospinal fluid of patients taking phenothiazines. Lancet 1987; 2: 596–599
   PubMed Web of Science ®Google Scholar
• Reddy V. N. Glutathione and its function in the lens—an overview. Experimental Eye Research 1990; 50: 771–778
   PubMed Web of Science ®Google Scholar
• Roberts J., Francetic D., Zera R. Chemoprotection against cyclophosphamide-induced urotoxicity: Comparison of nine thiol protective agents. Anticancer Research 1994; 14: 389–396
   PubMed Web of Science ®Google Scholar
• Romano M., Razandi M., Raza A., Szabo S., Ivey J. Cysteamine protects gastric epithelial cell mono-layers against drug induced damage: evidence for direct cellular protection by sulphydryl compounds. Gut 1992; 33: 30–38
   PubMed Web of Science ®Google Scholar
• Sagar S. M., Landry D., Millard W. J., Badger T. M., Arnold M. A., Martin J. B. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine. Journal of Neuroscience 1982; 2: 225–231
   PubMed Web of Science ®Google Scholar
• Salama G., Abramson J., Pike G. Sulphydryl reagents trigger Ca2+ release from the sarcoplasmic reticulum of skinned rabbit psoas fibres. Journal of Physiology 1992; 454: 389–420
   PubMed Web of Science ®Google Scholar
• Sharp A. H., McPherson P. S., Dawson T. M., Aoki C., Campbell K. P., Snyder S. H. Differential immunohistochemical localization of inositol 1,4.5-trisphosphate-and ryanodine-sensitive Ca2+ release channels in rat brain. Journal of Neuroscience 1993; 13(1)3051–3063
   PubMed Web of Science ®Google Scholar
• Sian J., Dexter D., Lees A., Daniel S., Agid Y., Iavoy-Agid F., Jenner P., David Marsen C. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Annals of Neurology 1994; 36: 348–355
   PubMed Web of Science ®Google Scholar
• Tariq M., Al-Deeb S., Al-Moutairy K., Mujeebuddin S., Arshaduddin M., Bruyn W. G. Effect of selenium and vitamin E on iminodipropionitrile induced dyskinesia in rats. International Journal of Neuroscience 1994; 78: 185–192
   PubMedGoogle Scholar
• Tatsuta M., Iishi H., Baba M., Taniguchi H. Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenetic effect of cysteamine on gastric carcinogenesis induced by N-methyl-N1-nitro-N-nitrosoguanidine in Wistar rats. International Journal of Cancer 1991; 48(4)605–608
   PubMed Web of Science ®Google Scholar
• Terry L. C., Craig R. Cysteamine effects on monoamines, dopamine B-hydroxylase and the hypothalamic-pituitary axis. Neuroendocrinohgy 1985; 41: 467–475
   PubMed Web of Science ®Google Scholar
• Timenstein M. A., Reed D. J. Characterization of glutathione-dependent inhibition of lipid peroxidation of isolated rat liver nuclei. Archives of Biochemistry and Biophysics 1988; 261: 1–11
   PubMed Web of Science ®Google Scholar
• Van den Broeke L. T., Beyersbergen Van Henegouwen G. M. UV-radiation protecting efficacy of thiols, studied with UVA-induced binding of 8-MOP and CPZ to rat epidermal biomacromolecules in vivo. International Journal of Radiation Biology 1993; 63(4)493–500
   PubMed Web of Science ®Google Scholar
• Vecsei L., Alling C., Widerlov E. Comparative studies of intracerebroventricularly administered cysteamine and pantethine in different behavioral tests and on brain catecholamines in rats. Archives of International Pharmacodynamics and Therapeutics 1990; 305: 140–151
   PubMedGoogle Scholar
• Winkler B. S. In vitro oxidation of ascorbic acid and its prevention by GSH. Biochemistry Biophysics Acta 1987; 925: 258–264
   PubMed Web of Science ®Google Scholar
• Yong V. W., Perry T. L., Krisman A. A. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3-6-tetrahydropyridine is prevented by antioxidant pretreatment. Neuroscience Letters 1986; 63: 56–60
   PubMed Web of Science ®Google Scholar